Table 1 Administrative information for Lagos COVID-19 Treatment Trial (LACTT)
Title {1} | A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of Chloroquine Phosphate, Hydroxychloroquine Sulphate and Lopinavir/Ritonavir for the Treatment of COVID-19 in Lagos State, Nigeria |
Trial registration {2a and 2b}. | The trial was registered with the Pan African Clinical Trials Register on April 2nd, 2020 with registration number PACTR202004801273802. The URL of the registry record is https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10928. |
Protocol version {3} | 20th July 2020, version number: 3.0. |
Funding {4} | Lagos State Government |
Author details {5a} | 1Lagos State Ministry of Health, Lagos, Nigeria 2Lagos State Primary Health Care Board, Lagos, Nigeria 3Nigerian Institute of Medical Research, Lagos, Nigeria 4Lagos State University College of Medicine, Lagos, Nigeria 5Lagos State University Teaching Hospital, Lagos, Nigeria 6Lagos State Health Management Agency, Lagos, Nigeria |
Name and contact information for the trial sponsor {5b} | Dr. Olusegun Ogboye, BSc, MBBS, MPH Permanent Secretary, Lagos State Ministry of Health, Lagos, Nigeria. |
Role of sponsor {5c} | The study sponsor and funder do not have a role in the design; collection, management, analysis, and interpretation of data; writing of the report; and the decision to submit the this or other manuscripts for publication. |